Icosavax, Inc

Call
Website
1930 Boren Ave Ste 1000
Seattle, WA 98101
+1 (206) 737-0085
https://icosavax.com

Icosavax, Inc. is a clinical-stage biotechnology company based in Seattle, WA, dedicated to developing innovative vaccines using their unique virus-like particle (VLP) technology. Their VLPs are designed to mimic the structure of viruses, offering potential advantages such as a stronger immune response, broader coverage against related viral strains and mutations, longer durability, and easier combinability for multiple targets in one vaccine.

With a focus on protecting vulnerable older adults from respiratory viruses, Icosavax aims to revolutionize the field of vaccines by creating a new era of immunization. Their cutting-edge approach has garnered attention, leading to an agreement to be acquired by AstraZeneca and positive interim Phase 2 results for their combination VLP vaccine candidate, IVX-A12, against respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in older adults.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Nonresidential construction, nec, nec, Blood derivatives

Just-Evotec Biologics

Just-Evotec Biologics is an integrated design company based in Seattle, WA, specializing in the discovery and development of high-quality biotherapeutics. With a focus on innovative technologies, they aim to expand global access to life-changing protein therapeutics while reducing manufacturing costs. Their AI-driven platform, J.DESIGN, offers a streamlined solution for biologics development challenges, from discovery to clinical and pivotal cGMP manufacturing. With a team of experienced professionals, Just-Evotec Biologics provides a full suite of CDMO services and flexible capacity at their advanced biologics development and manufacturing facilities.Generated from the website
In Bios International Inc
Surgical instruments and apparatus, Biological research

In Bios International Inc

In Bios International Inc, based in Seattle, is a cutting-edge biotech company specializing in developing innovative diagnostics for infectious diseases. The company's recent success in securing funding to create a novel Lyme disease diagnostic test showcases their commitment to advancing healthcare through technology and research. Generated from their website's infomation

Sengine Precision Medicine

SEngine Precision Medicine is a Seattle-based company that specializes in personalized cancer treatments and drug development. Their innovative approach combines 3D organoid technology and proprietary algorithms to provide more effective treatment options and accelerate drug development. By testing over 200 cancer drugs against a patient's unique tumor organoid, SEngine's high-throughput technology decodes the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. Additionally, the company leverages aggregated test results to develop new cancer-fighting drugs. SEngine Precision Medicine's PARIS Test is a game-changer in cancer care, delivering effective treatment options for solid tumors up to 80% of the time, compared to the estimated 15% prediction rate of DNA sequencing alone. As a CLIA-certified lab, SEngine is the only lab that provides actionable reports directly to oncologists, empowering patients and healthcare professionals with more informed treatment decisions. With a focus on improving patient outcomes today and transforming cancer care tomorrow, SEngine Precision Medicine is making a significant impact on the lives of cancer patients.Generated from the website
United States›Washington›Seattle›Icosavax, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.